NAECB NAECB Immunotherapy & Allergen Management

Question 1

Allergen immunotherapy (AIT) works primarily by:

Accepted Answer

Inducing immune tolerance through repeated allergen exposure

Answer

Blocking beta-2 receptors

Answer

Suppressing cortisol production

Answer

Eliminating IgE from circulation permanently

Question 2

The build-up phase of subcutaneous allergen immunotherapy (SCIT) typically involves:

Accepted Answer

Weekly injections with increasing allergen doses

Answer

Monthly injections at a fixed dose

Answer

Daily oral drops at maximum dose

Answer

Single high-dose injection quarterly

Question 3

What is the recommended observation period after each subcutaneous immunotherapy injection in a US clinic?

Accepted Answer

20–30 minutes

Answer

5 minutes

Answer

15 minutes

Answer

60 minutes

Question 4

Sublingual immunotherapy (SLIT) tablets approved in the US are indicated for which conditions?

Accepted Answer

Grass pollen, dust mite, and ragweed allergies

Answer

Cat and dog dander allergy only

Answer

Mold and cockroach allergy only

Answer

Food allergies exclusively

Question 5

Which of the following is an absolute contraindication to initiating allergen immunotherapy?

Accepted Answer

Severe or uncontrolled asthma (FEV1 < 70% predicted)

Answer

Mild persistent asthma with controlled symptoms

Answer

History of seasonal allergic rhinitis

Answer

Positive skin prick test to grass pollen

Question 6

How long should maintenance allergen immunotherapy typically be continued to achieve lasting clinical benefit?

Accepted Answer

3–5 years

Answer

6 months

Answer

1 year

Answer

Lifelong